LTR Pharma Limited
LTPLF
$0.27
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.78% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.78% | 837.89% | |||
| Cost of Revenue | -2.73% | -- | |||
| Gross Profit | 2.75% | -889.44% | |||
| SG&A Expenses | -2.74% | -0.28% | |||
| Depreciation & Amortization | 0.00% | -- | |||
| Other Operating Expenses | -2.66% | -42.60% | |||
| Total Operating Expenses | -2.75% | -35.12% | |||
| Operating Income | 2.74% | 44.80% | |||
| Income Before Tax | 2.74% | 44.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.74% | 44.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.74% | 44.64% | |||
| EBIT | 2.74% | 44.80% | |||
| EBITDA | 2.75% | -- | |||
| EPS Basic | 3.77% | 49.04% | |||
| Normalized Basic EPS | 3.03% | 49.23% | |||
| EPS Diluted | 3.77% | 49.04% | |||
| Normalized Diluted EPS | 3.03% | 49.23% | |||
| Average Basic Shares Outstanding | 0.00% | 9.97% | |||
| Average Diluted Shares Outstanding | 0.00% | 9.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||